Skip to content
Search

Latest Stories

Bestway Healthcare CEO Seb Hobbs retires, Greg Pateras named as successor

Bestway Healthcare CEO Seb Hobbs retires, Greg Pateras named as successor

Bestway Healthcare announces the retirement of CEO Seb Hobbs due to family health reasons 

Hobbs, who joined the company in 2019, navigated it through the challenges of the COVID-19 pandemic, and successfully oversaw the acquisition and integration of Lexon in 2023. He will retire from the company at the end of September 2024.


“After five years with the company, I am retiring at the end of September to spend time with my wife who was diagnosed with motor neurone disease last year,” Hobbs said.

“I wish to extend my personal thanks to our owners, the Bestway Group, for their kindness and understanding of our situation.

“It has been a privilege to lead the Well Pharmacy, now Bestway Healthcare organisation. The business is resilient for today and fit to prosper in the long term. When I leave it will be with gratitude and admiration for the 7,500+ people in Bestway Healthcare who are committed to improving the lives of our patients and customers, thank you all.”

Greg Pateras is set to assume leadership thereafter. He will join the company by the end of July 2024, undergoing an intensive induction process before taking on the CEO role in September.

Pateras brings extensive experience from senior leadership roles in multi-site retail organisations, including serving as CFO at Shop Direct, COO and Deputy CEO at Matalan, and CEO at Frasers Fashion.

Commenting on his appointment, Pateras said: “I am genuinely honoured that the owners at Bestway Group have given me the opportunity to lead Bestway Healthcare.

“I think the scale of the business with its integrated model, along with its ambitious owners and passionate colleagues leave us well placed in the continuously changing healthcare market.

“I really look forward to joining the great team that Seb has put together, who play such an important role in supporting pharmacists and healthcare professionals in improving the lives of millions of people.”

Lord Choudrey CBE SI Pk, Chair of Bestway Group and Bestway Healthcare, expressed gratitude on behalf of the Group for Seb's contributions to the business.

“On behalf of the Board of Bestway Group and the wider Bestway family I would like to place on record my personal thanks to Seb for all he has done for the business and also to wish him and Emma all the best going forward.

He also congratulated Greg on his new appointment, wishing him every success as he leads the business into the future

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less